The Capital Group Companies, Inc. reduced its holding of INNOVENT BIO (01801) by approximately 3,327,400 shares at a price of around HK$31.55 per share.
On January 20th, The Capital Group Companies, Inc. reduced its holdings in Sino Biopharmaceutical (01801) by 3,327,405 shares, priced at 31.5469 Hong Kong dollars per share, for a total amount of approximately 105 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on January 20, The Capital Group Companies, Inc. reduced its holdings of INNOVENT BIO (01801) by 3,327,405 shares, at a price of 31.5469 Hong Kong dollars per share, with a total amount of approximately 105 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 96,778,400 shares, with a shareholding proportion of 5.91%.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


